AArkstore enterprise 20th Novenber 2014
Panic Disorder Ther apeutics - Pipeline Assessment and Market Forecasts to Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60359/panic-disorder-therapeuticspipeline-assessment-and-market-forecasts Published: Feb 2012 | No. Of Pages: 73 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
2019
Summary The industry analysis specialist, has released its new report, “Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Panic Disorder Therapeutics market. The report identifies the key trends shaping and driving the global Panic Disorder Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Panic Disorder Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Website : http://www.aarkstore.com/
AArkstore enterprise Scope The report provides information on the key drivers and challenges of the Panic Disorder Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Panic Disorder Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Panic Disorder Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Panic Disorder Therapeutics market. - Analysis of key recent licensing and partnership agreements in Panic Disorder Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Panic Disorder Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Panic Disorder Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Website : http://www.aarkstore.com/
AArkstore enterprise - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Panic Disorder Therapeutics market landscape? – Identify, understand and capitalize.
Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com
Tables Of Contents 2 Panic Disorder Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Panic Disorder 2.1.2 Panic Attack 2.1.3 Difference between Panic Attacks and Panic Disorder
Website : http://www.aarkstore.com/
AArkstore enterprise 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Gender 2.2.3 Economic Burden 2.2.4 Quality of Life Parameters 2.3 Pathophysiology 2.3.1 Neurochemical Involvement 2.3.2 Etiology 2.3.3 Genetic and Biologic Theories 2.3.4 Psychological Theories 2.4 Signs and Symptoms 2.5 Diagnosis 2.5.1 Comorbidity 2.5.2 Rating Scales 2.6 Treatment and Management Pattern 2.6.1 Psychological treatment 2.6.2 Pharmacological Treatment 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 Panic Disorder Therapeutics - Market Characterization 3.1 Overview 3.2 Panic Disorder Therapeutics Market Size (2006-2011) - Global 3.3 Panic Disorder Therapeutics Market Forecast (2011-2019) - Global
Website : http://www.aarkstore.com/
AArkstore enterprise 3.4 Panic Disorder Therapeutics Market Size (2006-2011) - the US 3.5 Panic Disorder Therapeutics Market Forecast (2011-2019) - the US 3.6 Panic Disorder Therapeutics Market Size (2006-2011) - France 3.7 Panic Disorder Therapeutics Market Forecast (2011-2019) - France 3.8 Panic Disorder Therapeutics Market Size (2006-2011) - Germany 3.9 Panic Disorder Therapeutics Market Forecast (2011-2019) - Germany 3.10 Panic Disorder Therapeutics Market Size (2006-2011) - Italy 3.11 Panic Disorder Therapeutics Market Forecast (2011-2019) - Italy 3.12 Panic Disorder Therapeutics Market Size (2006-2011) - Spain 3.13 Panic Disorder Therapeutics Market Forecast (2011-2019) - Spain 3.14 Panic Disorder Therapeutics Market Size (2006-2011) - the UK 3.15 Panic Disorder Therapeutics Market Forecast (2011-2019) - the UK 3.16 Panic Disorder Therapeutics Market Size (2006-2011) - Japan 3.17 Panic Disorder Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Panic Disorder Therapeutics Market 3.18.1 Drivers for the Panic Disorder Therapeutics Market 3.18.2 Barriers for the Panic Disorder Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Panic Disorder Therapeutics - Competitive Assessment 4.1 Overview 4.1.1 Strategic Competitor Assessment 4.2 Product Profiles, Major Marketed Products in the Panic Disorder Therapeutics Market
Website : http://www.aarkstore.com/
AArkstore enterprise 4.2.1 Selective Serotonin Reuptake Inhibitors 4.2.2 Serotonin-Nonadrenaline Reuptake Inhibitors 4.2.3 Benzodiazepines 4.2.4 Tricyclic Antidepressants 4.3 Key Takeaway 5 Panic Disorder Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Panic Disorder Therapeutics Pipeline - Pipeline by Phases of Development 5.3.1 Panic Disorder Therapeutics - Phase II Pipeline 5.4 Panic Disorder Therapeutics Market - Clinical Pipeline by Mechanism of Action 5.5 Technology Trends Analytic Framework 5.6 Panic Disorder Therapeutics - Promising Drugs under Clinical Development 5.7 Molecule Profile for Promising Drugs under Clinical Development 5.7.1 AZ-002 (Staccato alprazolam) 5.7.2 ABIO-08/01 5.8 Key Takeaway 6 Panic Disorder Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Top Companies Participating in Panic Disorder Therapeutics Clinical Trials
Website : http://www.aarkstore.com/
AArkstore enterprise 7 Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Panic Disorder Therapeutics - Implications for Future Market Competition 8 Panic Disorder Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Alexza Pharmaceuticals 8.2.2 BTG International (BTG) 9 Licensing and Partnership Deals 10 Panic Disorder Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables
Website : http://www.aarkstore.com/
AArkstore enterprise Table 1: Comparison of Germany with Estimates of Costs from the US (€PPP, 2010) Table 2: Cost Per Person with Panic Disorder Table 3: Recommended Starting And Therapeutic Doses of SSRIs for Panic Disorder Table 4: Panic Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 5: Panic Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 6: Panic Disorder Therapeutics Market, the US, Revenue ($m), 2006-2011 Table 7: Panic Disorder Therapeutics Market, the US, Forecast ($m), 2011-2019 Table 8: Panic Disorder Therapeutics Market, France, Revenue ($m), 2006-2011 Table 9: Panic Disorder Therapeutics Market, France, Forecast ($m), 2011-2019 Table 10: Panic Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 11: Panic Disorder Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 12: Panic Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 13: Panic Disorder Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 14: Panic Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 15: Panic Disorder Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 16: Panic Disorder Therapeutics Market, the UK, Revenue ($m), 2006-2011 Table 17: Panic Disorder Therapeutics Market, the UK, Forecast ($m), 2011-2019 Table 18: Panic Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 19: Panic Disorder Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 20: SSRIs Approved for Panic Disorder Table 21: Adverse Events Incidence in Panic Disorder Placebo-Controlled Clinical Trials Table 22: Adverse Events Incidence in Placebo Controlled Clinical Trials Table 23: Adverse Events in Placebo Controlled Clinical Trials for Panic Disorder
Website : http://www.aarkstore.com/
AArkstore enterprise Table 24: Adverse Events in Short Term Placebo Controlled Effexor XR Clinical Trials in Panic Disorder Patients Table 25: Benzodiazepines Approved for Panic Disorder Table 26: Panic Disorder Therapeutics, Phase II Pipeline, 2011 Table 27: Panic Disorder Therapeutics - Most Promising Drugs under Clinical Development, 2011 Table 28: Panic Disorder Therapeutics, Clinical Trials by Country, 2011 Table 29: Panic Disorder Therapeutics, Clinical Trials by Phase, 2011 Table 30: Panic Disorder Therapeutics, Clinical Trials by Status of Development, 2011 Table 31: Panic Disorder Therapeutics, Prominent Sponsors, 2011 Table 32: Panic Disorder Therapeutics, Top Companies Participating in Therapeutics Clinical Trials, 2011 Table 33: Alexza Pharmaceuticals - Neuroscience Pipeline, 2011 Table 34: Alexza Pharmaceuticals - Panic Disorder Pipeline, 2011 Table 35: BTG - Neuroscience Therapeutics Pipeline Products, 2011 Table 36: BTG - Panic Disorder Therapeutics Pipeline Products, 2011 Table 37: Panic Disorder Therapeutics, Global, Deals, 2009-2011
List Of Figures Figure 1: Type of Anxiety Disorders Figure 2: Panic Attack : Cognitive Behavioral Therapy Model Figure 3: Life Time and 12 Month Prevalence of Panic Disorder, the US Figure 4: Unchecked Panic: A "Triple A" Threat Figure 5: Symptoms of Panic Disorder Figure 6: Difference between the Diagnostic Criteria for Panic Disorder by ICD-10 and DSM-IV Figure 7: Diagnostic Criteria for Panic Disorder Without Agoraphobia
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 8: Comorbidity Associated with Panic Disorder Figure 9: Panic Disorder Treatment Options Figure 10: Referral Pathway for Panic Disorder Figure 11: Panic Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 12: Panic Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 13: Panic Disorder Therapeutics Market, the US, Revenue ($m), 2006-2011 Figure 14: Panic Disorder Therapeutics Market, the US, Forecast ($m), 2011-2019 Figure 15: Panic Disorder Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 16: Panic Disorder Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 17: Panic Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 18: Panic Disorder Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 19: Panic Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 20: Panic Disorder Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 21: Panic Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 22: Panic Disorder Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 23: Panic Disorder Therapeutics Market, the UK, Revenue ($m), 2006-2011 Figure 24: Panic Disorder Therapeutics Market, the UK, Forecast ($m), 2011-2019 Figure 25: Panic Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 26: Panic Disorder Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 27: Opportunity and Unmet Need in the Panic Disorder Therapeutics Market for SSRIs and Benzodiazepines, 2011 Figure 28: Panic Disorder Therapeutics, Strategic Competitor Assessment, 2011 Figure 29: Panic Disorder Therapeutics, Technology Trends Analytics Framework, 2011 Figure 30: Panic Disorder Therapeutics, Technology Trends Analytics Framework, Description, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 31: Panic Disorder Therapeutics, Clinical Trials by Country, 2011 Figure 32: Panic Disorder Therapeutics, Clinical Trials by Phase (%), 2011 Figure 33: Panic Disorder Therapeutics, Clinical Trials by Status of Development (%), 2011 Figure 34: Panic Disorder Therapeutics, Overall Sponsors (%), 2011 Figure 35: Panic Disorder Therapeutics, Prominent Sponsors (%), 2011 Figure 36: Panic Disorder Therapeutics, Top Companies Participating in Clinical Trials, 2011 Figure 37: Panic Disorder Therapeutics Market, Drivers and Restraints, 2011 Figure 38: Implications for Future Market Competition in the Panic Disorder Market, 2011 Figure 39: Panic Disorder Therapeutics Market, Pipeline by Company, 2011 Figure 40: GlobalData Market Forecasting Model
Discount reports: HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Website : http://www.aarkstore.com/
AArkstore enterprise Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60359/panic-disorder-therapeuticspipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/
AArkstore enterprise
Website : http://www.aarkstore.com/